SCHEMBL26312258

SCHEMBL26312258

ClC(Cl)c1c2c3c(ccc2cc2[n+]1CCc1cc4c(cc1-2)OCO4)OCO3

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.55
METTL3 Q86U44 1/20 0.54
METTL14 Q9HCE5 1/20 0.54
XBP1 P17861 3/20 0.45
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MEN1 O00255 2/20 0.42
KDM1A O60341 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
BCHE P06276 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26312242 0.81 BCHE (0.59) IDO1ALDH1A1LMNAMAPTSMN1; SMN2
Coptisine SCHEMBL156866 0.71 IDO1 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL31392604 0.71 IDO1 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL29931632 0.71 IDO1 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL2441815 0.70 IDO1 (0.98) IDO1METTL3METTL14ALDH1A1LMNA
Coptisine SCHEMBL154528 0.70 METTL3 (1.00) IDO1METTL3METTL14ALDH1A1LMNA
SCHEMBL15624081 0.69 BCHE (0.52) IDO1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL298574 0.69 BCHE (0.62) IDO1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL14513580 0.67 BCHE (0.63) IDO1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL14513581 0.67 BCHE (0.63) IDO1ALDH1A1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725006-B2 Hydrophilic berberine-type derivative and application thereof in preparing drug INSTITUTE OF MATERIA MEDIC, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2023-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725006-B2 Hydrophilic berberine-type derivative and application thereof in preparing drug SLC7A1, ABCB11, ABCC1 IDO1 2696/4885METTL3 3178/4885METTL14 2974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.